Free Trial

Takeda Pharmaceutical (TAK) News Today

Takeda Pharmaceutical logo
$14.68 +0.11 (+0.75%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$14.66 -0.02 (-0.14%)
As of 05/27/2025 05:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TAK Latest News

Takeda Pharmaceutical Company Limited stock logo
Forum Financial Management LP Raises Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Forum Financial Management LP boosted its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 133.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 114,324 shares of the company's stock af
Takeda Pharmaceutical Company Limited stock logo
GTS Securities LLC Makes New Investment in Takeda Pharmaceutical Company Limited (NYSE:TAK)
GTS Securities LLC bought a new stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 97,558 shares of the company's stock, valued at approximately $1,292,000
Takeda Pharmaceutical Company Limited stock logo
26,600 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Bought by Point72 Asset Management L.P.
Point72 Asset Management L.P. bought a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 26,600 shares of the company's stock, valued at approximately $352,000. A number of othe
Takeda Pharmaceutical Company Limited stock logo
510,600 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Acquired by Toronto Dominion Bank
Toronto Dominion Bank purchased a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 510,600 shares of the company's stock, valu
Takeda Pharmaceutical Company Limited stock logo
Millennium Management LLC Sells 1,655,703 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)
Millennium Management LLC cut its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 45.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,000,903 shares of the company's stock after selling 1,655,703 sha
Takeda Pharmaceutical Company Limited stock logo
Janus Henderson Group PLC Has $3.10 Million Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Janus Henderson Group PLC decreased its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 8.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 233,950 shares of the co
Takeda Pharmaceutical Company Limited stock logo
Soleus Capital Management L.P. Purchases 680,000 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)
Soleus Capital Management L.P. raised its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 136.0% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,180,000 shares of the company's stock after acquiring an addit
Takeda Pharmaceutical Company Limited stock logo
Focus Partners Wealth Raises Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Focus Partners Wealth lifted its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 431.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 79,499 shares of the company's stock after acqui
Takeda Pharmaceutical Company Limited stock logo
Quantinno Capital Management LP Increases Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Quantinno Capital Management LP raised its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 33.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48
Takeda Pharmaceutical Company Limited stock logo
Dimensional Fund Advisors LP Increases Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Dimensional Fund Advisors LP grew its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 60.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 181,929 shares of
Takeda Pharmaceutical Company Limited stock logo
230,000 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Purchased by LMR Partners LLP
LMR Partners LLP acquired a new stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 230,000 shares of the company's stock, valued at approximately $3,045,000. A nu
Takeda Pharmaceutical Company Limited stock logo
Takeda Pharmaceutical Company Limited (NYSE:TAK) Holdings Raised by Hudson Bay Capital Management LP
Hudson Bay Capital Management LP lifted its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 10.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 275,000 shares of the company's stock after purchasin
Takeda Pharmaceutical Company Limited stock logo
Balyasny Asset Management L.P. Invests $2.56 Million in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Balyasny Asset Management L.P. bought a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 193,203 shares of the company's stock, valued at ap
Takeda Pharmaceutical Company Limited stock logo
BNP Paribas Financial Markets Has $6.63 Million Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)
BNP Paribas Financial Markets increased its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 15,449.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 500,677 shares of the company's stock
Takeda Pharmaceutical Company Limited stock logo
Takeda Pharmaceutical Company Limited (NYSE:TAK) Stake Increased by Jane Street Group LLC
Jane Street Group LLC boosted its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 109.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 254,647 shares of the company
Takeda Pharmaceutical Company Limited stock logo
Takeda Pharmaceutical (NYSE:TAK) Shares Gap Down - Should You Sell?
Takeda Pharmaceutical (NYSE:TAK) Shares Gap Down - What's Next?
Takeda Pharmaceutical Company Limited stock logo
Ethic Inc. Sells 113,512 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)
Ethic Inc. lowered its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 25.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 326,307 shares of the company's stock afte
Takeda Pharmaceutical Company Limited stock logo
Northern Trust Corp Purchases 238,161 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)
Northern Trust Corp increased its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 14.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,873,588 shares of the company's stock after
Takeda Pharmaceutical Company Limited stock logo
Takeda Pharmaceutical (NYSE:TAK) Announces Earnings Results
Takeda Pharmaceutical (NYSE:TAK - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.24 by ($0.08). The business had revenue of $7.34 billion during the quarter, compared to the consensus estimate of $8.02 billion. Takeda Pharmaceutical had a return on equity of 9.39% and a net margin of 4.53%.
Takeda Pharmaceutical Company Limited stock logo
Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Ellevest Inc.
Ellevest Inc. lowered its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 48.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 40,379 shares of the company's stock after selling 38,549 shares during the
Takeda Pharmaceutical Company Limited stock logo
Cubist Systematic Strategies LLC Acquires New Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Cubist Systematic Strategies LLC bought a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 446,764 shares of the company's stock, valued at approx
Takeda Pharmaceutical Company Limited stock logo
Schonfeld Strategic Advisors LLC Has $865,000 Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Schonfeld Strategic Advisors LLC lowered its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 21.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 65,351 shares of the company's stock after selling 17,851 shares during
Takeda Pharmaceutical Company Limited stock logo
Takeda Pharmaceutical (NYSE:TAK) Updates FY 2025 Earnings Guidance
Takeda Pharmaceutical (NYSE:TAK) updated its FY 2025 earnings guidance. The company provided EPS guidance of 3.180-3.180 for the period.
Takeda Pharmaceutical Company Limited stock logo
Takeda Pharmaceutical (NYSE:TAK) Hits New 52-Week High - Still a Buy?
Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month High - Time to Buy?
Takeda Pharmaceutical Company Limited stock logo
Lido Advisors LLC Invests $364,000 in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Lido Advisors LLC purchased a new stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,487 shares of the
Takeda Pharmaceutical Company Limited stock logo
Takeda Pharmaceutical Company Limited (NYSE:TAK) Stock Position Lifted by Tower Research Capital LLC TRC
Tower Research Capital LLC TRC lifted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 413.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20
Takeda Pharmaceutical Company Limited stock logo
Raymond James Financial Inc. Purchases New Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Raymond James Financial Inc. acquired a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 109,317 shares of the c
Takeda Pharmaceutical Company Limited stock logo
Marshall Wace LLP Buys Shares of 76,254 Takeda Pharmaceutical Company Limited (NYSE:TAK)
Marshall Wace LLP purchased a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 76,254 shares of the company's stock, valued at approximately $1,010,000. A number of other l
Takeda Pharmaceutical Company Limited stock logo
Aquatic Capital Management LLC Buys 61,927 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)
Aquatic Capital Management LLC increased its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 52.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 180,927 shares of the company's stoc
Takeda Pharmaceutical Company Limited stock logo
JPMorgan Chase & Co. Has $1.11 Million Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)
JPMorgan Chase & Co. boosted its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 94.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 83,826 shares of the company's stock after purchasi
Takeda Pharmaceutical Company Limited stock logo
Syon Capital LLC Has $486,000 Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Syon Capital LLC lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 41.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 36,680 shares of the company's stock after selling 25,626 shares during the period. S
Takeda Pharmaceutical Company Limited stock logo
Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Acquired by Mariner LLC
Mariner LLC raised its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 14.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 142,504 shares of the company's stock after purchasing an
Takeda Pharmaceutical Company Limited stock logo
Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Purchased by First Trust Advisors LP
First Trust Advisors LP boosted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,240,932 shares of the company's stock afte
Get Takeda Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter.

TAK Media Mentions By Week

TAK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TAK
News Sentiment

1.24

1.03

Average
Medical
News Sentiment

TAK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TAK Articles
This Week

7

5

TAK Articles
Average Week

Get Takeda Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:TAK) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners